carcinogenicity and mutagenicity data: new initiatives to

65
Office of Research and Development National Center for Computational Toxicology Carcinogenicity and Mutagenicity Data: New Initiatives to Improve Access & Utility for Modeling http://www.epa.gov/ncct/toxcast April 2-4, 2008 SCARLET Workshop, Milan, Italy

Upload: others

Post on 21-Nov-2021

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Carcinogenicity and Mutagenicity Data: New Initiatives to

Office of Research and DevelopmentNational Center for Computational Toxicology

Carcinogenicity and Mutagenicity Data: New Initiatives to Improve Access & Utility for Modeling

http://www.epa.gov/ncct/toxcast

April 2-4, 2008SCARLET Workshop, Milan, Italy

Page 2: Carcinogenicity and Mutagenicity Data: New Initiatives to

Part IPart IData & Data LinkagesData & Data Linkages

Page 3: Carcinogenicity and Mutagenicity Data: New Initiatives to

http://www.epa.gov/ncct/dsstox/

Page 4: Carcinogenicity and Mutagenicity Data: New Initiatives to
Page 5: Carcinogenicity and Mutagenicity Data: New Initiatives to
Page 6: Carcinogenicity and Mutagenicity Data: New Initiatives to

Toxicity Experimental Data Summary Data:

ToxML

++__

Intermediate Intermediate toxicity toxicity

classificationsclassificationsfor SARfor SARActivity categories

Potency categories

Mode of action categories

Summary calls

Chronic toxicityGenetic toxicity

Skin sensitizationDevelopmental toxicity

ToxML / LIST Collaborations: FDA CDER/CFSAN

Page 7: Carcinogenicity and Mutagenicity Data: New Initiatives to

DSSToxDSSToxSummary Summary ToxicityToxicity

Data FilesData Files

Toxicity Data ModelsToxicity Data Models

Page 8: Carcinogenicity and Mutagenicity Data: New Initiatives to

CPDBAS_v5a_1547

STRUCTUREDSSTox_RIDDSSTox_CIDDSSTox_Generic_SIDDSSTox_FileIDSTRUCTURE_FormulaSTRUCTURE_MolecularWeightSTRUCTURE_ChemicalTypeSTRUCTURE_TestedForm

_DefinedOrganicSTRUCTURE_ShownTestSubstance_ChemicalNameTestSubstance_CASRNTestSubstance_DescriptionChemicalNoteSTRUCTURE_ChemicalName

_IUPACSTRUCTURE_SMILESSTRUCTURE_Parent_SMILESSTRUCTURE_InChIStudyTypeEndpointSpecies

Mutagenicity_SAL_CPDBTD50_Rat_mgTD50_Rat_mmolTD50_Rat_NoteTargetSites_Rat_Male, Female, Both SexesTD50_Mouse_mgTD50_Mouse_mmolTD50_Mouse_NoteTargetSites_Mouse_Male, Female, Both SexesTD50_Hamster_mgTD50_Hamster_mmolTD50_Hamster_NoteTargetSites_Hamster_Male, Female, Both SexesTD50_Dog_mgTargetSites_DogTD50_Rhesus_mgTargetSites_RhesusTD50_Cynomolgus_mgTargetSites_CynomolgusTD50_Dog_Rhesus_Cynomolgus_NoteActivityCategory_SingleCellCallActivityCategory_MultiCellCallActivityCategory_MultiCellCall_DetailsToxicityNoteNTP_TechnicalReportWebsite_URL

adrenal gland; bone; clitoral gland; esophagus; ear/Zymbal’s gland; gall bladder; harderian gland; hematopoietic system; kidney; large intestine; liver; lung; mesovarium; mammary gland; mixture; myocardium; nasal cavity nervous system; oral cavity ovary; pancreas;peritoneal cavity; pituitary gland; preputial gland; prostate; skin; small intestine; spleen; stomach; subcutaneous tissue; all tumor bearing animals; testes; thyroid gland; urinary bladder; uterus; vagina; vascular system.

01

multisite active; multisex active; multispecies activemultisex inactive;multispecies inactive

Page 9: Carcinogenicity and Mutagenicity Data: New Initiatives to

CPDBAS_v5b_1547_10Feb2008

Page 10: Carcinogenicity and Mutagenicity Data: New Initiatives to
Page 11: Carcinogenicity and Mutagenicity Data: New Initiatives to

Activity Overlap for CPDBAS MultiCellCall Results

DSSTox NTPHTS Download Page

12940 DSSTox Substances

Page 12: Carcinogenicity and Mutagenicity Data: New Initiatives to

11 DSSTox “Bioassays”

1. AID 1194: CPDBAS Salmonella Mutagenicity 403 /860 Active2. AID 1189: CPDBAS SingleCellCall 806 /1547Active3. AID 1205: CPDBAS MultiCellCall 582 /1152Active4. AID 1208 CPDBAS Rat Bioassay (M/F/Both) 587 /1240 Active5. AID 1199: CPDBAS Mouse Bioassay (M/F/Both) 445 /1007Active7. AID 1190: CPDBAS Dog & Primates Bioassay 15 /32Active8. AID 1195: FDAMDD – FDA Maximum Daily Dose 1216 /1216 Active9. AID 1204: NCTRER – NCTR Estrogen Receptor Binding 131 /232 Active10. AID 1188: EPA Fathead Minnow Acute Toxicity 580 /617 Active11. AID 1201: EPA Disinfection By-Products Carcinogenicity Estimates 80 /209 Active

Page 13: Carcinogenicity and Mutagenicity Data: New Initiatives to

Activity Overlap for CPDBAS MultiCellCall Results

Page 14: Carcinogenicity and Mutagenicity Data: New Initiatives to

http://www.epa.gov/ncct/dsstox/

Page 15: Carcinogenicity and Mutagenicity Data: New Initiatives to

http://www.epa.gov/dsstox_structurebrowser/

Page 16: Carcinogenicity and Mutagenicity Data: New Initiatives to
Page 17: Carcinogenicity and Mutagenicity Data: New Initiatives to
Page 18: Carcinogenicity and Mutagenicity Data: New Initiatives to

DSSTox Structure-Browser

EPA IRIS Website

Page 19: Carcinogenicity and Mutagenicity Data: New Initiatives to

Links directly to chemical data page for Aniline in PubChem

Page 20: Carcinogenicity and Mutagenicity Data: New Initiatives to
Page 21: Carcinogenicity and Mutagenicity Data: New Initiatives to

DSSTox SDF Files &

Documentation

DSSTox Structure-Browser

EPA HPV Information

System

EPA IRIS Summary

CPDB

NTP

PubChem

EPA ACToRDSSTox

Page 22: Carcinogenicity and Mutagenicity Data: New Initiatives to

DSSTox Stru

cture

DSSTox Stru

cture--Browser

Browser

CPDB, IRIS, N

TP, HPV

CPDB, IRIS, N

TP, HPV--ISIS

PubChemPubChem

EPA ACTOREPA ACTOR

ToxN

etTo

xNet

Page 23: Carcinogenicity and Mutagenicity Data: New Initiatives to

Part IIPart IIToxicity ProfilingToxicity Profiling

Page 24: Carcinogenicity and Mutagenicity Data: New Initiatives to

National Academy of Sciences Report (2007)Toxicity Testing in the Twenty-first Century: A Vision and a Strategy

Page 25: Carcinogenicity and Mutagenicity Data: New Initiatives to

The DNA Damage Response: 10 Years After[Harper & Elledge, Mol Cell 14:739, 2007]

Page 26: Carcinogenicity and Mutagenicity Data: New Initiatives to

http://www.epa.gov/ncct/toxcast/

Science: Feb 15, 2008

Page 27: Carcinogenicity and Mutagenicity Data: New Initiatives to

CellularAssays

Biochemical Assays

Toxicology Endpoints

Physical chemical propertiesProfile Matching

Correlating Domain Outputs

Genomic Signatures

EPA ToxCast Goal:Assess broad biological effect patterns and correlate with the patterns of known toxicants for forecasting potential for hazard

Page 28: Carcinogenicity and Mutagenicity Data: New Initiatives to

Office of Research and DevelopmentNational Center for Computational Toxicology 27

ToxCast Phase I Objective: Derive Predictive Signatures for Chemical Prioritization

Sufficient number and diversity of chemicalsAvailability of high quality reference in vivo toxicity

data covering broad range of endpointsExpectation of broad spectrum biological activityProperties suitable for HTSCost and availability

Requirements for Chemical Selection:

Page 29: Carcinogenicity and Mutagenicity Data: New Initiatives to

Office of Research and DevelopmentNational Center for Computational Toxicology 28

ToxCast Phase I Chemicals

1

10

100

1000

10000

100000

Data Collection

IRISTRIPesticide ActivesCCL 1&2Pesticide InertsHPVMPV CurrentMPV HistoricalTSCA Inventory

Many well characterized

Few well characterized

11,000

90,000

ToxCast_320

Page 30: Carcinogenicity and Mutagenicity Data: New Initiatives to

Office of Research and DevelopmentNational Center for Computational Toxicology 29

Prioritize List of ~840 Pesticide Actives

Data availability

Toxicological interest

Environmental relevance

Pesticide Registration RecordsPesticide Registration Records

DSSTox File IncidenceDSSTox File Incidence

Page 31: Carcinogenicity and Mutagenicity Data: New Initiatives to

Office of Research and DevelopmentNational Center for Computational Toxicology 30

Meet minimal HTS phys-chem requirementsSoluble in DMSO / waterNot highly volatileMolecular Weight in approx range [100-1,000]Available in ~pure or standard form with structure

Span diverse structural space

Include clusters of similar chemicals

Prioritize Chemicals for ToxCast Phase I: Chemical Characteristics

Page 32: Carcinogenicity and Mutagenicity Data: New Initiatives to

Office of Research and DevelopmentNational Center for Computational Toxicology 31

309 Unique Structures

Replicates for QC

291 Pesticide Actives9 Industrial Chemicals8 Metabolites

56/73 Proposed Tier 1 EDSP

14 HPV11 HPV Challenge

Chemical Classes in ToxCast_320 (Phase I) CHLORINE

ORGANOPHOSPHORUSAMIDEESTERETHERPYRIDINEFLUORINECARBOXYLIC ACIDPHENOXYKETONETRIAZINECARBAMATEPHOSPHOROTHIOATEPYRIMIDINEBENZENEORGANOCHLORINEAMINEPYRETHROIDSULFONYLUREATRIAZOLEUREAIMIDAZOLENITRILEALCOHOLCYCLOPHOSPHORODITHIOATETHIOCARBAMATEANILINETHIAZOLEDINITROANILINEOXAZOLEPHOSPHATEIMINENITROPHENOLPHTHALIMIDEPYRAZOLESULFONAMIDE

Misc (<4 members)

Page 33: Carcinogenicity and Mutagenicity Data: New Initiatives to

Office of Research and DevelopmentNational Center for Computational Toxicology 32

Mode-of-Action Classes in ToxCast_320 (Phase I)

MOA Classes with > 3 chemicals

Misc MOA classes with3 or fewer representatives

Acetylcholine esterase inhibitorsconazole fungicidesSodium channel modulatorspyrethroid ester insecticidesorganothiophosphate acaricidesdinitroaniline herbicidespyridine herbicidesthiocarbamate herbicidesimidazolinone herbicidesorganophosphate insecticidesphenyl organothiophosphate insecticidesaliphatic organothiophosphate insecticidesamide herbicidesaromatic fungicideschloroacetanilide herbicideschlorotriazine herbicidesgrowth inhibitorsorganophosphate acaricidesoxime carbamate insecticidesphenylurea herbicidespyrethroid ester acaricidesstrobilurin fungicidesunclassified acaricidesunclassified herbicides

Misc

Classification based on OPPIN

Page 34: Carcinogenicity and Mutagenicity Data: New Initiatives to
Page 35: Carcinogenicity and Mutagenicity Data: New Initiatives to

Office of Research and DevelopmentNational Center for Computational Toxicology 34

EPA Pesticide Programs:Data Evaluation Records (DERs)

• Used for hazard identification and characterization

• Study Types– Chronic– Cancer– Subchronic– Multigeneration– Developmental– Others: DNT, Neurotox, Immunotox, Mutagenicity

• Derive Endpoints (NOAEL/LOAEL)– Systemic– Parental– Offspring– Reproductive– Maternal– Developmental

• Critical Effects for Endpoints

DER Format• Study Identifiers

– Tested Chemical Information• IDs• Name• Purity

– Study Type IDs– Reviewer Information

• Citation(s)• Executive Summary

– Summary Study Design– Summary Effects– Endpoints (NOAEL/LOAEL)

• Test Material– Purity– Source– Physical/Chemical Properties

• Animal Information– Species– Strain– Husbandry

• Results (full dose-response)– Clinical signs– Body weight– Clinical Chemistry/ Hematology– Gross Pathology– Non-neoplastic Pathology– Neoplastic Pathology– Parental vs. Offspring– Maternal vs. Fetal

$10,000,000

Page 36: Carcinogenicity and Mutagenicity Data: New Initiatives to

Office of Research and DevelopmentNational Center for Computational Toxicology 35

Extraction of DER information

Page 37: Carcinogenicity and Mutagenicity Data: New Initiatives to

Office of Research and DevelopmentNational Center for Computational Toxicology 36

ToxRefDB: Toxicity Reference Database

Page 38: Carcinogenicity and Mutagenicity Data: New Initiatives to

Office of Research and DevelopmentNational Center for Computational Toxicology 37

Page 39: Carcinogenicity and Mutagenicity Data: New Initiatives to

Office of Research and DevelopmentNational Center for Computational Toxicology

Rodent SubchronicRat MultiGen Mouse CancerRat Chronic/

CancerRabbit DevelRat Devel

235268 264

273

230

73 76

233

278266

Data Entry StatusToxCast Phase I Chemicals Only

Total: 291 Pesticides

Current as of February 8, 2008

270280

Page 40: Carcinogenicity and Mutagenicity Data: New Initiatives to

Office of Research and DevelopmentNational Center for Computational Toxicology

Minimum Dose at which specific effects observed(mg/kg/day)

Chemicals

Effects

Page 41: Carcinogenicity and Mutagenicity Data: New Initiatives to

Office of Research and DevelopmentNational Center for Computational Toxicology

ToxCast HTS Assay Contractors and Collaborators

40

The Home of TFomics TM

attageneattageneattageneattagene

Compound Focus, Inc.a subsidiary of

Nine contracts, one IAG and an MOU provide chemical procurement; hundreds of

biochemical, cellular, tissue and genomic assays; model organisms; and the capacity to

screen up to 10,000 chemicals

Page 42: Carcinogenicity and Mutagenicity Data: New Initiatives to

41

Multiple concentration (5) data underwayHamner InstitutesPrecision-cutTissue slices

Rat liver, lung, kidney11Tissue Slice

Culture

Multiple concentration (11) data from 2 of 10 assays delivered

NIH Chemical Genomics Center

Nuclear receptor reporter gene assays

Human and rodent10+10+uHTS

22,433265TOTAL

Multiple concentration (3) data underway for 20 chemicalsPhylonixTeratogenesisDanio rerio111Zebrafish

Multiple concentration (10) data deliveredCellumenImaging cytotoxicityHepG2 cells (human liver)111HCS

Multiple concentration (4) data deliveredBioseekCell signaling pathways

Primary human cells878Complex Cell

Culture

Multiple concentration (8) data underwayIVALCytotoxicity, shared metabolism

Human liver, lung, kidney

cells61Cell Co-

Culture

Multiple concentration (8) data deliveredACEA BiosciencesReal time electrical impedance

A549 cells (human lung)Kinetic1Kinetic Cell

Growth

Multiple concentration (5) in rat system underway

IVAL and Expression

AnalysisPCR, microarrays

Hepatocyte-Kupffer co-

culture22,0001Genomics

Single concentration data delivered; multiple concentration to followAttageneNuclear receptor,

transcription factorHepG2 cells

(human liver)672Reporter Gene Assays

Single concentration data delivered; multiple concentration to followNovaScreenEnzyme inhibition,

receptor bindingHuman, rat,

other240240HTS

ToxCast_320 Status 04dec2007SourceCommentAssay Source# Endpoints# AssaysAssay Type

Multiple concentration (5) data underwayHamner InstitutesPrecision-cutTissue slices

Rat liver, lung, kidney11Tissue Slice

Culture

Multiple concentration (11) data from 2 of 10 assays delivered

NIH Chemical Genomics Center

Nuclear receptor reporter gene assays

Human and rodent10+10+uHTS

22,433265TOTAL

Multiple concentration (3) data underway for 20 chemicalsPhylonixTeratogenesisDanio rerio111Zebrafish

Multiple concentration (10) data deliveredCellumenImaging cytotoxicityHepG2 cells (human liver)111HCS

Multiple concentration (4) data deliveredBioseekCell signaling pathways

Primary human cells878Complex Cell

Culture

Multiple concentration (8) data underwayIVALCytotoxicity, shared metabolism

Human liver, lung, kidney

cells61Cell Co-

Culture

Multiple concentration (8) data deliveredACEA BiosciencesReal time electrical impedance

A549 cells (human lung)Kinetic1Kinetic Cell

Growth

Multiple concentration (5) in rat system underway

IVAL and Expression

AnalysisPCR, microarrays

Hepatocyte-Kupffer co-

culture22,0001Genomics

Single concentration data delivered; multiple concentration to followAttageneNuclear receptor,

transcription factorHepG2 cells

(human liver)672Reporter Gene Assays

Single concentration data delivered; multiple concentration to followNovaScreenEnzyme inhibition,

receptor bindingHuman, rat,

other240240HTS

ToxCast_320 Status 04dec2007SourceCommentAssay Source# Endpoints# AssaysAssay Type

Page 43: Carcinogenicity and Mutagenicity Data: New Initiatives to

Office of Research and DevelopmentNational Center for Computational Toxicology 42

AttageneHeatmap

67 Assays

320

Che

mic

als

Page 44: Carcinogenicity and Mutagenicity Data: New Initiatives to

Part IIIPart IIIIncorporating SAR Concepts Incorporating SAR Concepts

into ToxCastinto ToxCast

Page 45: Carcinogenicity and Mutagenicity Data: New Initiatives to

Bioassay DataBioassay Data

ToxRef DB, NTP, IRIS, etc

ToxCast: Multidimensional Data

Biochemical, Cell-based, …HTS Data HTS Data

Chemical StructuresChemical StructuresN

NNH

O

O

NH

O

CH3

CH3

O

N

O

SCl

ClCl

Cl

Cl

O

O

OHP

NHO

S OO

CH3

CH3

CH3

Page 46: Carcinogenicity and Mutagenicity Data: New Initiatives to

Bioassay DataBioassay Data

Global modeling

SummaryActivity

+/-

Large chemical coverage

Uses no prior chemical knowledge

Calculated descriptors, properties, fragments

Chemical StructuresChemical Structures

Structure-Activity Approaches to Toxicity Prediction

O

N

O

SCl

ClCl

N

NNH

O

O

NH

O

CH3

CH3

Cl

Cl

O

O

OHP

NHO

S OO

CH3

CH3

CH3

Page 47: Carcinogenicity and Mutagenicity Data: New Initiatives to

Bioassay DataBioassay Data

Chemical Class-Based Modeling

SummaryActivity

+/-

Limited chemical coverage

Heavy reliance on perceived “chemical similarity”

Assumes chemical class equates to MOA

Calculated descriptors, properties, fragments

N

NNH

O

O

NH

O

CH3

CH3

Cl

Cl

O

O

OHP

NHO

S OO

CH3

CH3

CH3

Structure-Activity Approaches to Toxicity Prediction

O

N

O

SCl

ClCl

Page 48: Carcinogenicity and Mutagenicity Data: New Initiatives to

Oncologic Carcinogenicity Estimation Expert System:Chemical Class – Based Prediction Modules

Acyl and Benzoyl Halide Type Compounds Acrylate Reactive Functional GroupsAcrylamide Reactive Functional GroupsAflatoxin Type CompoundsAldehyde Type CompoundsAliphatic Azo and Azoxy Type CompoundsAlkanesulfonoxy Ester Type CompoundsAlkyl Sulfate and Alkyl Alkanesulfonate Type CompoundsAromatic Amine Type CompoundsAnhydride Type CompoundsArylazo Type CompoundsAryldiazonium SaltsC-Nitroso and Oxime Type CompoundsCarbamate Type CompoundsCarbamyl Halide Type CompoundsCoumarin and Furocoumarin Type Compounds Dicarbonyl Type CompoundsEpoxide Reactive Functional GroupsEthyleneimine Reactive Functional GroupsHaloalkylamine Reactive Functional GroupsHaloether Reactive Functional GroupsHalogenated Aromatic Hydrocarbon Type Compounds Halogenated Cycloalkane Type Compounds

ortho-Halogenated Heterocyclic Type CompoundsHalogenated Nitroaromatic Type CompoundHalogenated Linear Aliphatic Type CompoundsHalothioether Reactive Functional GroupsHydrazo Type CompoundsReactive Ketone Reactive Functional GroupsLactone Type Reactive Functional GroupsNitrosamide Type CompoundsNitrosamine Type CompoundsNitroalkane and Nitroalkene Type CompoundsNitrogen Mustard Reactive Functional GroupsOrganophosphorus Type CompoundPeroxide Type CompoundsPhenol Type CompoundsPhosgene Type CompoundsPolycyclic Aromatic Hydrocarbons -HeterocyclicPolycyclic Aromatic Hydrocarbons -Homocyclic Siloxane Type CompoundsReactive Sulfone Reactive Functional GroupsSulfur Mustard Reactive Functional GroupsSultone Reactive Functional GroupsThiocarbamate Type CompoundsThiocarbonyl Type CompoundsTriazene Type CompoundsUrea Type Compounds

Organophosphorus Type Compound

Page 49: Carcinogenicity and Mutagenicity Data: New Initiatives to

P R3R1

R2

X

P

R3R1

R2

PN

R1

R2

CH2CH2Cl

phosphate-type phosphine-type

cyclophosphamide-type

R1/R2/R3 = alkyl groups or aryl groups

P X-alkyl or X-aryl where X is oxygen, sulfur or in some cases nitrogen, linking the phosphorus to the alkyl/aryl group

phosphine-type phosphine and phosphine-oxide

cyclophosphamide-type cyclophosphamide, isophosphamide, trophosphamide

R1/R2/R3: alkyl (Cn), hydrogen (H), benzyl (CH2C6H5), phenyl (C6H5),Morpholino, NR’R” (where R’R” can be one of the above).

X1/X2/X3/X4: Oxygen (O), Sulfur (S)

Substituents: Halogens (Cl, Br, I, F), hydroxyl (OH), carboxylic acid (COOH), sulfonicacid (SO3H) and additionally alkyl (Cn) on the aryl ring..

Organophosphate

Oncologic Carcinogenicity Estimation Expert System:

Page 50: Carcinogenicity and Mutagenicity Data: New Initiatives to

1111-

11101

11100

11011

11010

1100-

+

-

Rapid hydrolysis?

Strong chelating property?

Combining SAR and Biofunctional Information in Oncologic: Predicting Carcinogenicity of Organophosphates

-

+

-

LM+

L

High acute toxicity?

Increase serumalkaline phosphatase?

Mar+

-M

LM

-HM

+

Woo et al. (1996) Environ. Carc. & Ecotox. Revs., C14:1-42

In vitro genotoxicity?

In vivogenotoxicity?

Organophosphate

Page 51: Carcinogenicity and Mutagenicity Data: New Initiatives to

Oncologic Carcinogenicity Estimation Expert System:Chemical Class – Based Prediction Modules

Acyl and Benzoyl Halide Type Compounds Acrylate Reactive Functional GroupsAcrylamide Reactive Functional GroupsAflatoxin Type CompoundsAldehyde Type CompoundsAliphatic Azo and Azoxy Type CompoundsAlkanesulfonoxy Ester Type CompoundsAlkyl Sulfate and Alkyl Alkanesulfonate Type CompoundsAromatic Amine Type CompoundsAnhydride Type CompoundsArylazo Type CompoundsAryldiazonium SaltsC-Nitroso and Oxime Type CompoundsCarbamate Type CompoundsCarbamyl Halide Type CompoundsCoumarin and Furocoumarin Type Compounds Dicarbonyl Type CompoundsEpoxide Reactive Functional GroupsEthyleneimine Reactive Functional GroupsHaloalkylamine Reactive Functional GroupsHaloether Reactive Functional GroupsHalogenated Aromatic Hydrocarbon Type Compounds Halogenated Cycloalkane Type Compounds

ortho-Halogenated Heterocyclic Type CompoundsHalogenated Nitroaromatic Type CompoundHalogenated Linear Aliphatic Type CompoundsHalothioether Reactive Functional GroupsHydrazo Type CompoundsReactive Ketone Reactive Functional GroupsLactone Type Reactive Functional GroupsNitrosamide Type CompoundsNitrosamine Type CompoundsNitroalkane and Nitroalkene Type CompoundsNitrogen Mustard Reactive Functional GroupsOrganophosphorus Type CompoundPeroxide Type CompoundsPhenol Type CompoundsPhosgene Type CompoundsPolycyclic Aromatic Hydrocarbons -HeterocyclicPolycyclic Aromatic Hydrocarbons -Homocyclic Siloxane Type CompoundsReactive Sulfone Reactive Functional GroupsSulfur Mustard Reactive Functional GroupsSultone Reactive Functional GroupsThiocarbamate Type CompoundsThiocarbonyl Type CompoundsTriazene Type CompoundsUrea Type Compounds

Organophosphorus Type Compound

1111-

11101

11100

11011

11010

1100-101001111100000000000010100000000101001… 01100101010000…

Page 52: Carcinogenicity and Mutagenicity Data: New Initiatives to

NAM

E

CYP

2C19

CY

P2C

9

CY

P3A

1

Dop

amin

e Tr

ansp

orte

r (H

uman

)

CY

P2D

2

And

roge

n R

ecep

tor

Dop

amin

e Tr

ansp

orte

r (R

at)

CYP

2B6

CY

P2D

1

CY

P3A4

Prog

este

rone

Rec

epto

r

Ben

zodi

azep

ine

Rec

epto

r

Cyproconazole 1 1 1 1 1 0 1 0 0 1 0 0Difenoconazole 1 1 1 1 1 0 0 1 1 0 0 0Diniconazole 1 1 1 0 1 0 0 0 1 1 1 0Fenbuconazole 1 1 0 0 0 0 0 0 0 1 0 0Flusilazole 1 1 1 0 1 1 0 1 1 NA 1 1Hexaconazole 1 1 1 1 1 0 1 1 1 NA 1 0Imazalil 1 1 1 1 1 1 1 1 1 1 1 1Myclobutanil 1 1 1 1 0 0 0 0 0 NA 0 0Paclobutrazol 1 0 1 1 0 1 1 0 1 1 0 0Prochloraz 1 1 1 1 1 1 1 1 1 NA 1 1Propiconazole 1 1 1 0 0 0 0 1 0 NA 0 1Tetraconazole 1 1 1 0 1 1 0 1 0 1 1 0Triadimefon 1 1 0 1 1 1 1 0 0 1 0 1Triadimenol 1 0 0 1 0 1 1 0 0 0 0 0Triflumizole 1 1 1 1 1 1 0 1 1 1 1 1Triticonazole 1 1 1 1 0 1 1 0 0 NA 0 0Totals 16 14 13 11 10 9 8 8 8 8 7 6

Patterns can inform SAR

Chemical structures can suggest basis for activity differences

N

NNH

O

O

NH

O

CH3

CH3

Cl

Cl

O

O

OHP

NHO

S OO

CH3

CH3

CH3

O

N

O

SCl

ClCl

Bioactivity Profile of Structure Class

Sample HTS Results for Conazoles

Page 53: Carcinogenicity and Mutagenicity Data: New Initiatives to

Cluster according to activity and mechanism

Differences in activity profiles can discriminate within structure class

Chemical structure class:

Can project onto multiple chemical classes

Potentially broader coverage of chemical space

Implies mechanistic similarity

Bioactivity profile class:

Che

mic

als

Assays

N

NNH

O

O

NH

O

CH3

CH3

O

N

O

SCl

ClCl

Cl

Cl

O

O

OHP

NHO

S OO

CH3

CH3

CH3

Structure Class vs Bioactivity Class

Page 54: Carcinogenicity and Mutagenicity Data: New Initiatives to

Bioassay DataBioassay Data

SAR modeling

SummaryActivity

+/-

Structure-Activity Approaches to Toxicity Prediction

Cl

Cl

O

O

OHP

NHO

S OO

CH3

CH3

CH3

HTS Data HTS Data

HTSActivityClusters

Chemical StructuresChemical StructuresO

N

O

SCl

ClCl

N

NNH

O

O

NH

O

CH3

CH3

Incorporate HTS Assay Data (+/-) as Biological “descriptors”

MR

PG

R

GR

AR

FXR

PP

AR

_bet

a

VD

R

LXR

_alp

ha

PP

AR

_gam

ma

PX

R

LXR

_alp

ha

PP

AR

_alp

ha

RX

R_a

lpha

theory

00.0010.0020.0030.0040.0050.0060.0070.0080.0090.01

In silico generation of target-binding for use

in prediction

Page 55: Carcinogenicity and Mutagenicity Data: New Initiatives to

ToxRef DB

ToxRef DB provides detailed hierarchical toxicity data model

Linkage to chemical structures enables flexible SAR and data mining

Bioassay DataBioassay Data

Use of Bioassay Activity Categories in SAR

SAR modeling

SummaryActivity

+/-

In vivoActivityClusters SAR

Chemical StructuresChemical StructuresN

NNH

O

O

NH

O

CH3

CH3

Cl

Cl

O

O

OHP

NHO

S OO

CH3

CH3

CH3

O

N

O

SCl

ClCl

Page 56: Carcinogenicity and Mutagenicity Data: New Initiatives to

ToxRefDB Profiling of Liver Effects for Pesticides

Activity Profile is refined “Endpoint” for

SAR modeling

Page 57: Carcinogenicity and Mutagenicity Data: New Initiatives to

Bioassay DataBioassay Data

Biochemical, Cell-based, …HTS Data HTS Data

ToxRef DB, NTP, IRIS, etc

Structure-Analog Approaches

SARSAR

Chemical StructuresChemical StructuresN

NNH

O

O

NH

O

CH3

CH3

O

N

O

SCl

ClCl

Cl

Cl

O

O

OHP

NHO

S OO

CH3

CH3

CH3

Page 58: Carcinogenicity and Mutagenicity Data: New Initiatives to

ToxCast: Data Publication & Exploration

Summarized endpoint data for use in SAR modeling

HTS data

Register ToxCast Substances in PubChem

Page 59: Carcinogenicity and Mutagenicity Data: New Initiatives to

ToxCast_320

Bioactivity Analysis:

Retrieve all bioassay data in PubChem for ToxCast_320

482 Bioassays45 Compounds

Selected bioassays

Page 60: Carcinogenicity and Mutagenicity Data: New Initiatives to

Show details for 7 Bioassays

Page 61: Carcinogenicity and Mutagenicity Data: New Initiatives to

Structure-ActivityBioactivity Analysis:

7 bioassays, 45 Actives

View Bioassay Profile by Structure Similarity Cluster

Page 62: Carcinogenicity and Mutagenicity Data: New Initiatives to

View bioassay profile of structure similarity cluster

Page 63: Carcinogenicity and Mutagenicity Data: New Initiatives to

Similar Bioassay Profile across structure space

Page 64: Carcinogenicity and Mutagenicity Data: New Initiatives to

Office of Research and DevelopmentNational Center for Computational Toxicology

HTS data offers:activity-based clustering of chemicalsbiofunctional information for refining class-based SARnew “biological” descriptors for global SAR

In vivo bioassay profiles expanding “endpoints” for SAR

Structure-analog approaches coupled with HTS and ToxRefin vivo data offer powerful data mining tools

Public tools for structure-based exploration of data becoming available

Incorporating SAR Concepts into ToxCast: Conclusions

Page 65: Carcinogenicity and Mutagenicity Data: New Initiatives to

Acknowledgements:EPA DSSTox Team:

Maritja Wolf (DSSTox) and Tom Transue (Structure-browser) – Lockheed Martin, Contractors to the US EPA

NIEHS/NTP – NTP HTS Program:Ray Tice, Cynthia Smith, Beth Bowden, Brad Collins

NCCT ToxCast Team:Robert Kavlock (Director, NCCT)David Dix (ToxRefDB, HTS, Genomics)Keith Houck (HTS)Matt Martin (ToxRefDB)Richard Judson (ACToR)Rocky Goldsmith (Modeling)

ToxML: Chihae Yang – Leadscope

UNC-CH School of Pharmacy: Alex Tropsha, Hao Zhu, Ivan Rusyn

PubChem Project: Steve Bryant, Yanli Wang, Jane Tseng

Carcinogenic Potency Project: Lois Gold

NIH Chemical Genomics Center: Chris Austin, Ajit Jadhav

This work was reviewed by EPA and approved for publication but does not necessarily reflect official Agency policy.